Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Q4 2023 Earnings Conference Call October 12, 2023 8:30 AM ET
Company Participants
Tiffany Kanaga - Vice President, Global Investor Relations
Tim Wentworth - Chief Executive Officer
Ginger L. Graham - Interim Chief Executive Officer
Manmohan Mahajan - Interim Global Chief Financial Officer
John Driscoll - President of U.S. Healthcare
Rick Gates - Senior Vice President and Chief Pharmacy Officer
Conference Call Participants
Lisa Gill - JP Morgan
Charles Rhyee - TD Cowen
George Hill - Deutsche Bank
Kevin Caliendo - UBS
Brian Tanquilut - Jefferies
Elizabeth Anderson - Evercore ISI
Eric Percher - Nephron Research
Operator
Good morning. My name is Christa, and I will be your conference operator today. At this time, I would like to welcome everyone to the Walgreens Boots Alliance, Inc. Fourth Quarter and Fiscal Year 2023 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.
Tiffany Kanaga, Vice President of Global Investor Relations, you may begin your conference.
Tiffany Kanaga
Good morning. Thank you for joining us for the Walgreens Boots Alliance earnings call for the fourth quarter of fiscal year 2023. I'm Tiffany Kanaga, Vice President of Global Investor Relations. Joining me on today's call are Ginger Graham, our Interim Chief Executive Officer; Manmohan Mahajan, our Interim Global Chief Financial Officer; and John Driscoll, President of U.S. Healthcare. In addition, Rick Gates, Senior Vice President and Chief Pharmacy Officer at Walgreens and Tracey Brown, President of Walgreens Retail and Chief Customer Officer will participate in Q&A.
All references to the COVID-19 headwind on today’s call include U.S. vaccines, drive-through tests, and OTC tests. As always, during the conference call, we anticipate making projections and forward-looking statements based on our current expectations. Our actual results could differ materially due to a number of factors, including those listed on Slide 2 and those outlined in our latest form 10-K filed with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement after this presentation, whether as a result of new information, future events, changes in assumptions or otherwise.
You can find our press release and the slides referenced on this call in the Investors section of the Walgreens Boots Alliance website. The slides in the press release also contain further information about the non-GAAP financial measures that we will discuss during this call.